Frequency of Paraoxonase 192/55 Polymorphism in an Iranian Population

REFERENCES

• Adkins , S. , Gan , K. N. , Mody , M. and La Du , B. N. 1993 . Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: Gln or Arg at position 192, for the respective A or B allozymes . Am. J. Hum. Genet. , 40 : 277 – 282 .
   Google Scholar
• Akgur , S. A. , Ozturk , P. , Sozmen , E. Y. , Delen , Y. , Tanyalcin , T. and Ege , B. 1999 . Paroxonase and acetylcholinesterase activities in humans exposed to organophosphorous compounds . J. Toxicol. Environ. Health A , 58 : 469 – 474 .
   PubMed Web of Science ®Google Scholar
• Antikainen , M. , Murtomaki , S. , Syvanne , M. , Pahlman , R. , Tahvanainen , E. , Jauhiainen , M. , Frick , M. H. and Ehnholm , C. 1996 . The Gln-Arg191 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns . J. Clin. Invest. , 98 : 883 – 885 .
   PubMed Web of Science ®Google Scholar
• Aviram , M. , Ronsenblat , M. , Bisgaier , C. L. , Newton , R. S. , Primo-Parmo , S. L. and La Du , B. N. 1998 . Paraoxonase inhibits high-density lipoprotein and preserves its functions: A possible peroxidative role for paraoxonase . J. Clin. Invest. , 101 : 1581 – 1590 .
   PubMed Web of Science ®Google Scholar
• Aynacioglu , A. S. , Cascorbi , I. , Mrozikiewicz , P. M. , Nacak , M. , Tapanyigit , E. E. and Roots , I. 1999 . Paraoxonase1 mutations in a Turkish population . Toxicol. Appl.Pharmacol. , 157 : 174 – 177 .
   PubMed Web of Science ®Google Scholar
• Blatter-Garin , M. C. , James , R. W. , Dussoix , P. , Blanche , H. , Passa , P. , Froguel , P. and Ruiz , J. 1997 . Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes . J. Clin. Invest. , 99 : 62 – 66 .
   PubMed Web of Science ®Google Scholar
• Boright , A. P. , Connelly , P. W. , Brunt , J. H. , Scherer , S. W. , Tsui , L. C. and Hegele , R. A. 1998 . Genetic variation in paraoxonase-1 and paraoxonase-2 is associated with variation in plasma lipoproteins in plasma in Alberta Hutterites . Atherosclerosis , 139 : 131 – 136 .
   PubMed Web of Science ®Google Scholar
• Brophy , V. , Jarvik , G. and Furlong , C. 2002 . “ PON1 polymorphisms ” . In Paraoxonase (PON1) in health and disease: Basic and clinical aspects , Edited by: Costa , L. and Furlong , C. 53 – 77 . Boston : Kluwer Academic Press .
   Google Scholar
• Chen , J. , Kumar , M. , Chan , W. , Berkowitz , G. and Wetmur , J. G. 2003 . Increased influence of genetic variation on PON1 activity in neonates . Environ. Health Perspect. , 111 : 1403 – 1409 .
   PubMed Web of Science ®Google Scholar
• Davies , H. G. , Richter , R. J. , Kiefer , M. , Broombfield , C. A. , Sowala , J. and Furlong , C. E. 1996 . The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin . Nat. Genet. , 14 : 334 – 336 .
   PubMed Web of Science ®Google Scholar
• Deakin , S. P. and James , R. W. 2004 . Genetic and environmental factors modulating serum concentrations and activities of the antioxidant enzyme paraoxonase-1 . Clin. Sci. , 107 : 435 – 447 .
   PubMed Web of Science ®Google Scholar
• Draganov , D. I. and La Du , B. N. 2004 . Pharmacogenetics of paraoxonases: A brief review . Naunyn-Schmiedebergs Arch. Pharmacol. , 369 : 78 – 88 .
   PubMed Web of Science ®Google Scholar
• Ferretti , G. , Bacchetti , T. , Maratti , E. and Curatola , G. 2003 . Effect of homocysteinylation on human high-density lipoproteins: A correlation with paraoxonase activity . Metabolism , 52 : 146 – 151 .
   PubMed Web of Science ®Google Scholar
• Geldmacher-von Mallinckrodt , M. and Diepgen , T. L. 1988 . The human serum paraoxonase-polymorphism and specificity . Toxicol. Environ. Chem. , 18 : 79 – 196 .
   Web of Science ®Google Scholar
• Hegele , R. A. , Connelly , P. W. , Hanley , A. J. , Sun , F. , Harris , S. B. and Zinman , B. 1997 . Common genomic variants associated with variation in plasma lipoproteins in young aboriginal Canadians . Arterioscler. Thromb. Vasc. Biol. , 17 : 1060 – 1066 .
   PubMed Web of Science ®Google Scholar
• Herrmann , S. M. , Blanc , H. , Poirier , O. , Arveiler , D. , Luc , G. , Evans , A. , Marques-Vidal , P. , Bard , J. M. and Cambien , F. 1996 . The Gln:Arg polymorphism of human paraoxonase (PON192) is not related to myocardial infarction in the ECTIM study . Atherosclerosis , 126 : 299 – 303 .
   PubMed Web of Science ®Google Scholar
• Hong , S. H. , Song , J. , Min , W. K. and Kim , J. Q. 2001 . Genetic variations of the paraoxonase gene in patients with coronary artery disease . Clin. Biochem. , 34 : 475 – 481 .
   PubMed Web of Science ®Google Scholar
• Humbert , R. , Adler , D. A. , Disteche , C. M. , Hassett , C. , Omiecinski , C. J. and Furlong , C. E. 1993 . The molecular basis of the human serum paraoxonase activity polymorphism . Nat. Gen. , 3 : 73 – 76 .
   PubMed Web of Science ®Google Scholar
• Imai , Y. , Morita , H. , Kurihara , H. , Sugiyama , K. , Kato , N. , Ebihara , A. , Hamada , C. , Kurihara , Y. , Shindo , T. , Oh-Hashi , Y. and Yazaki , Y. 2000 . Evidence for association between paraoxonase gene polymorphism and atherosclerotic diseases . Atherosclerosis , 149 : 435 – 442 .
   PubMed Web of Science ®Google Scholar
• La Du , B. N. , Piko , J. I. , Eckerson , H. W. , Vincent-Viry , M. and Siest , G. 1986 . An improved method for phenotyping individuals for the human serum paraoxonase arylesterase polymorphism . Ann. Biol. Clin. , 44 : 369 – 372 .
   PubMed Web of Science ®Google Scholar
• Mackness , M. I. , Mackness , B. , Durrington , P. N. , Connelly , P. W. and Hegele , R. A. 1996 . Paraoxonase: Biochemistry, genetics and relationship to plasma lipoproteins . Curr. Opin. Lipidol. , 7 : 69 – 76 .
   PubMed Web of Science ®Google Scholar
• Mackness , B. , Mackness , M. I. , Arrol , S. , Turkie , W. and Durrington , P. N. 1998 . Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification . FEBS Lett. , 423 : 57 – 60 .
   PubMed Web of Science ®Google Scholar
• Mackness , M. I. , Harty , D. , Bhatnagar , D. , Winocour , P. H. , Arrol , S. , Ishola , M. and Durrington , P. N. 1991 . Serum paraoxonase activity in familial hypercholesterolemia and insulin-dependent diabetes mellitus . Atherosclerosis , 86 : 193 – 199 .
   PubMed Web of Science ®Google Scholar
• Miller , S. A. , Dykes , D. D. and Polesky , H. S. 1988 . Simple salting out procedure for extracting DNA from human nucleated cells . Nucleic Acids Res. , 16 : 1215
   PubMed Web of Science ®Google Scholar
• Reiner , E. , Svedružić , D. , Simeon-Rudolf , V. , Lipovac , V. , Gavella , M. and Mrzljak , V. 1999 . Paraoxonase and arylesterase activities in the serum of two hyperlipoproteinaemic patients after repeated extracorporeal lipid precipitation . Chem. Biol. Interact. , 119–120 : 405 – 411 .
   PubMed Web of Science ®Google Scholar
• Richter , R. J. and Furlong , C. E. 1999 . Determination of paraoxonase (PON1) status requires more than genotyping . Pharmacogenetics , 9 : 745 – 753 .
   PubMedGoogle Scholar
• Sanghera , D. K. , Saha , N. and Kamboh , M. I. 1998 . The codon 55 polymorphism in the paraoxonase 1 gene is not associated with the risk of coronary heart disease in Asian Indians and Chinese . Atherosclerosis , 136 : 217 – 223 .
   PubMed Web of Science ®Google Scholar
• Wang , X. , Fan , Z. , Huang , J. , Su , S. , Yu , Q. , Zhao , J. , Hui , R. , Yao , Z. , Shen , Y. , Qiang , B. and Gu , D. 2003 . Extensive association analysis between polymorphisms of PON gene cluster with coronary heart disease in Chinese Han population . Arterioscler. Thromb. Vasc. Biol. , 23 : 328 – 334 .
   PubMed Web of Science ®Google Scholar